BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36556513)

  • 21. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
    Lee HS; Hong H; Jung DC; Park S; Kim J
    Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Uchida Y; Yoshida S; Arita Y; Shimoda H; Kimura K; Yamada I; Tanaka H; Yokoyama M; Matsuoka Y; Jinzaki M; Fujii Y
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma.
    El-Shorbagy SH; Alshenawy HA
    J Microsc Ultrastruct; 2017; 5(2):90-96. PubMed ID: 30023241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
    Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Ng KL; Ellis RJ; Samaratunga H; Morais C; Gobe GC; Wood ST
    Transl Androl Urol; 2019 May; 8(Suppl 2):S123-S137. PubMed ID: 31236330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic value of mult-detector CT for papillary renal cell carcinoma and chromophobe renal cell carcinoma].
    Liu X; Zou X; Chen H; Fang X; Hu X; Sun R
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):52-6. PubMed ID: 25877320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of amylase α-1A, MOC 31, and
    Abouhashem NS; Abdelbary EH; H Abdalla MM; El-Shazly M
    Indian J Pathol Microbiol; 2020; 63(3):405-411. PubMed ID: 32769329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
    Conner JR; Hirsch MS; Jo VY
    Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
    Lüders C; Kristiansen G
    Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomogram predictive model for differentiation between renal oncocytoma and chromophobe renal cell carcinoma at multi-phasic CT: a retrospective study.
    Elsayed Sharaf D; Shebel H; El-Diasty T; Osman Y; Khater SM; Abdelhamid M; Abou El Atta HM
    Clin Radiol; 2022 Oct; 77(10):767-775. PubMed ID: 35764438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Texture analysis as a radiomic marker for differentiating renal tumors.
    Yu H; Scalera J; Khalid M; Touret AS; Bloch N; Li B; Qureshi MM; Soto JA; Anderson SW
    Abdom Radiol (NY); 2017 Oct; 42(10):2470-2478. PubMed ID: 28421244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
    Brennan K; Metzner TJ; Kao CS; Massie CE; Stewart GD; Haile RW; Brooks JD; Hitchins MP; Leppert JT; Gevaert O
    JCO Precis Oncol; 2020; 4():. PubMed ID: 33015531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can the multiphasic computed tomography be useful in the clinical management of small renal masses?
    Gaudiano C; Schiavina R; Vagnoni V; Busato F; Borghesi M; Bandini M; Di Carlo M; Brunocilla E; Martorana G; Golfieri R
    Acta Radiol; 2017 May; 58(5):625-633. PubMed ID: 27599523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade.
    Deng Y; Soule E; Samuel A; Shah S; Cui E; Asare-Sawiri M; Sundaram C; Lall C; Sandrasegaran K
    Eur Radiol; 2019 Dec; 29(12):6922-6929. PubMed ID: 31127316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
    Zhou J; Yang X; Zhou L; Zhang P; Wang C
    Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.